| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xu,Jin-Hui | Chairman | 4.31% | |
| Xie,De-Chong | Director | 3.41% | |
| Li,Shu-Zhi | Director | 2.04% | |
| Xie,Dong-Lian | Director | 1.18% | |
| Xu,Shi-Han | Independent Director | 0.00% | |
| Zhang,Yi-Jie | Independent Director | 0.00% | |
| Shen,Leng-Zhen | Independent Director | 0.10% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 378,879 | 2,268,560 | 2,189,249 |
| Operating cost | 318,453 | 1,893,357 | 1,780,906 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 60,426 | 375,203 | 408,343 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 60,426 | 375,203 | 408,343 |
| Operating expenses | 127,533 | 546,059 | 515,249 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -67,107 | -170,856 | -106,906 |
| Non-operating income and expenses | 41,581 | 130,985 | 84,784 |
| Net profit (loss) before tax | -25,526 | -39,871 | -22,122 |
| Income tax expense (benefits) | 0 | 634 | -3 |
| Net profit (loss) of ongoing business for the current period | -25,526 | -40,505 | -22,119 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -25,526 | -40,505 | -22,119 |
| Other comprehensive profit (loss), net | 26,364 | 37,272 | -13,171 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 838 | -3,233 | -35,290 |
| Net profit (loss) attributable to owners of parent company | -25,003 | -39,234 | -20,458 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -523 | -1,271 | -1,661 |
| Comprehensive profit (loss) attributable to owners of parent company | 1,361 | -1,962 | -33,629 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -523 | -1,271 | -1,661 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -24,588 | 35,795 | 558,201 |
| Net cash inflows (outflows) from investing activities | 6,855 | -55,287 | -41,315 |
| Net cash inflow (outflow) from financing activities | 52,284 | -16,470 | -258,876 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 16,678 | 17,433 | 110 |
| Increase (decrease) in cash and cash equivalents in the current period | 51,229 | -18,529 | 258,120 |
| Beginning balance of cash and cash equivalents | 913,195 | 931,724 | 673,604 |
| Ending balance of cash and cash equivalents | 964,424 | 913,195 | 931,724 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 2,143,541 | 2,142,542 | 2,112,367 |
| Non-current asset | 661,391 | 668,535 | 666,786 |
| Total asset | 2,804,932 | 2,811,077 | 2,779,153 |
| Current liability | 1,151,076 | 1,166,244 | 1,114,190 |
| Non-current liability | 147,708 | 139,523 | 156,420 |
| Total liability | 1,298,784 | 1,305,767 | 1,270,610 |
| share capital | 1,677,385 | 1,677,385 | 1,677,385 |
| Equity - secruity token | - | - | - |
| capital reserve | 291,899 | 291,899 | 291,899 |
| retained earning | -474,262 | -449,259 | -413,662 |
| Other equity | -4,475 | -30,839 | -64,474 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,490,547 | 1,489,186 | 1,491,148 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 15,601 | 16,124 | 17,395 |
| Total Equity | 1,506,148 | 1,505,310 | 1,508,543 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 8 | 8 | 8 |
